← Eichor
Condition: Tuberculosis Multi Drug Resistant Active Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tuberculosis Multi Drug Resistant Active

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of M
Phase 2 · 11 location(s) · Janssen Research & Development, LLC · NCT02354014Training Protocol on the Natural History of Tuberculosis
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01212003A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 3 · 2 location(s) · Shanghai Jiatan Pharmatech Co., Ltd · NCT05824871Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)
Phase 2 · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05534750Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) Durin
Phase 4 · 1 location(s) · Marco Schiuma · NCT07477119
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.